Clinical Trial Update: A Study of Intravesical FL115 Alone or in Combination With BCG in Non-Muscle Invasive Bladder Cancer [Phase 1, Phase 2]

View source ↗

Summary

This clinical trial update describes an ongoing Phase 1/Phase 2 study evaluating intravesical FL115 alone or in combination with BCG for non-muscle invasive bla…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-muscle Invasive Bladder Cancer

Drugs mentioned

• Bacillus Calmette-Guérin (Bacillus Calmette-Guérin)
• FL115

Snippet

Sponsor: Suzhou Forlong Biotechnology Co., Ltd | Conditions: Non-muscle Invasive Bladder Cancer (NMIBC) | Phase 1, Phase 2 | Status: RECRUITING